The board of California's stem cell research funding agency is riddled with conflicts of interest that threaten its credibility. That's according to a new report from independent experts.
Sponsored
upper waypoint
lower waypointnext waypoint
Stay in touch. Sign up for our daily newsletter.
To learn more about how we use your information, please read our privacy policy.